Department of Pharmacology

Translation of Orofacial Science

 

 

Professor Mike Hubbard

Translational Research Initiatives

TRI


Contact

E-mail: mike.hubbard@unimelb.edu.au

Office Address:
Department of Paediatrics
4th Floor, Front Entry Building
Royal Children's Hospital
Parkville 3052

Tel: +61 3 9345 5028 / 9345 5161(message)
Fax: +61 3 9345 6667

Lab Address:
Department of Pharmacology
Level 8, Room W829
Medical Building
Parkville 3010

Tel: +61 3 8344 8623
Fax: +61 3 8344 0241

Websites:

 

Qualifications:

Current Position:

Current Roles:

Short History:
Following graduation from the University of Otago (New Zealand) as a dentist, Mike did a PhD in Biochemistry (Otago), spent a year in private dental practice, then undertook postdoctoral positions investigating calcium signalling with Claude Klee (National Cancer Institute, NIH, USA) and protein phosphorylation with Sir Philip Cohen (University of Dundee, Scotland). On return to Otago in 1990, he established his independent research career focusing on the cells that form dental enamel. In 2003, Mike shifted camp to Melbourne where he currently works in the Paediatrics and Pharmacology Departments under auspice of the Melbourne Research Unit for Facial Disorders. His overall mission is to promote translational research in the oral and facial sciences, with a focus on prevalent tooth and bone problems.

New Translational Research Initiatives:

Since 2003, Mike has spear-headed development of the Melbourne Research Unit for Facial Disorders (MRUFD) into an effective translational research unit with active fronts in oral health and biomedical technology. First, he instigated a cross-sector technology network, now known as Proteomics & Metabolomics Victoria. This initiative has strengthened the sector through several key improvements (unity, technology access, communication, education, strategy & advocacy). Second, he instigated The D3 Group, a cross-sector network focused on Developmental Dental Defects (DDD=D3). This Australia-NZ network brings together a broad community (researchers, clinicians, public health, trade & affected families) with the common goal to improve the understanding and care of people with D3s. Much potential exists to expand these two initiatives alongside the ToothPrint proteomics database, a bioinformatics translational resource developed by Mike's group earlier. Having established these three key building blocks (clinical, technology, bioinformatics), unprecedented opportunities now exist for translating orofacial science through to public benefit. For further information, see the Melbourne Research Unit for Facial Disorders.

Core Research Interests:

An interest in calcium sparked during Mike's dental training led to research-career interests in several biochemical topics that have broad biomedical significance.

Recent Publications and Further Details:

 

 

 

top of page
Melbourne Research Unit for Facial Disorders Proteomics & Metabolomics Victoria Toothprint The D3 Group